Cargando…
Some principles for using epidemiologic study results to parameterize transmission models
BACKGROUND: Infectious disease models, including individual based models (IBMs), can be used to inform public health response. For these models to be effective, accurate estimates of key parameters describing the natural history of infection and disease are needed. However, obtaining these parameter...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593029/ https://www.ncbi.nlm.nih.gov/pubmed/37873220 http://dx.doi.org/10.1101/2023.10.03.23296455 |
_version_ | 1785124382771773440 |
---|---|
author | Joshi, Keya Kahn, Rebecca Boyer, Christopher Lipsitch, Marc |
author_facet | Joshi, Keya Kahn, Rebecca Boyer, Christopher Lipsitch, Marc |
author_sort | Joshi, Keya |
collection | PubMed |
description | BACKGROUND: Infectious disease models, including individual based models (IBMs), can be used to inform public health response. For these models to be effective, accurate estimates of key parameters describing the natural history of infection and disease are needed. However, obtaining these parameter estimates from epidemiological studies is not always straightforward. We aim to 1) outline challenges to parameter estimation that arise due to common biases found in epidemiologic studies and 2) describe the conditions under which careful consideration in the design and analysis of the study could allow us to obtain a causal estimate of the parameter of interest. In this discussion we do not focus on issues of generalizability and transportability. METHODS: Using examples from the COVID-19 pandemic, we first identify different ways of parameterizing IBMs and describe ideal study designs to estimate these parameters. Given real-world limitations, we describe challenges in parameter estimation due to confounding and conditioning on a post-exposure observation. We then describe ideal study designs that can lead to unbiased parameter estimates. We finally discuss additional challenges in estimating progression probabilities and the consequences of these challenges. RESULTS: Causal estimation can only occur if we are able to accurately measure and control for all confounding variables that create non-causal associations between the exposure and outcome of interest, which is sometimes challenging given the nature of the variables we need to measure. In the absence of perfect control, non-causal parameter estimates should still be used, as sometimes they are the best available information we have. CONCLUSIONS: Identifying which estimates from epidemiologic studies correspond to the quantities needed to parameterize disease models, and determining whether these parameters have causal interpretations, can inform future study designs and improve inferences from infectious disease models. Understanding the way in which biases can arise in parameter estimation can inform sensitivity analyses or help with interpretation of results if the magnitude and direction of the bias is understood. |
format | Online Article Text |
id | pubmed-10593029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-105930292023-10-24 Some principles for using epidemiologic study results to parameterize transmission models Joshi, Keya Kahn, Rebecca Boyer, Christopher Lipsitch, Marc medRxiv Article BACKGROUND: Infectious disease models, including individual based models (IBMs), can be used to inform public health response. For these models to be effective, accurate estimates of key parameters describing the natural history of infection and disease are needed. However, obtaining these parameter estimates from epidemiological studies is not always straightforward. We aim to 1) outline challenges to parameter estimation that arise due to common biases found in epidemiologic studies and 2) describe the conditions under which careful consideration in the design and analysis of the study could allow us to obtain a causal estimate of the parameter of interest. In this discussion we do not focus on issues of generalizability and transportability. METHODS: Using examples from the COVID-19 pandemic, we first identify different ways of parameterizing IBMs and describe ideal study designs to estimate these parameters. Given real-world limitations, we describe challenges in parameter estimation due to confounding and conditioning on a post-exposure observation. We then describe ideal study designs that can lead to unbiased parameter estimates. We finally discuss additional challenges in estimating progression probabilities and the consequences of these challenges. RESULTS: Causal estimation can only occur if we are able to accurately measure and control for all confounding variables that create non-causal associations between the exposure and outcome of interest, which is sometimes challenging given the nature of the variables we need to measure. In the absence of perfect control, non-causal parameter estimates should still be used, as sometimes they are the best available information we have. CONCLUSIONS: Identifying which estimates from epidemiologic studies correspond to the quantities needed to parameterize disease models, and determining whether these parameters have causal interpretations, can inform future study designs and improve inferences from infectious disease models. Understanding the way in which biases can arise in parameter estimation can inform sensitivity analyses or help with interpretation of results if the magnitude and direction of the bias is understood. Cold Spring Harbor Laboratory 2023-10-03 /pmc/articles/PMC10593029/ /pubmed/37873220 http://dx.doi.org/10.1101/2023.10.03.23296455 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Joshi, Keya Kahn, Rebecca Boyer, Christopher Lipsitch, Marc Some principles for using epidemiologic study results to parameterize transmission models |
title | Some principles for using epidemiologic study results to parameterize transmission models |
title_full | Some principles for using epidemiologic study results to parameterize transmission models |
title_fullStr | Some principles for using epidemiologic study results to parameterize transmission models |
title_full_unstemmed | Some principles for using epidemiologic study results to parameterize transmission models |
title_short | Some principles for using epidemiologic study results to parameterize transmission models |
title_sort | some principles for using epidemiologic study results to parameterize transmission models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593029/ https://www.ncbi.nlm.nih.gov/pubmed/37873220 http://dx.doi.org/10.1101/2023.10.03.23296455 |
work_keys_str_mv | AT joshikeya someprinciplesforusingepidemiologicstudyresultstoparameterizetransmissionmodels AT kahnrebecca someprinciplesforusingepidemiologicstudyresultstoparameterizetransmissionmodels AT boyerchristopher someprinciplesforusingepidemiologicstudyresultstoparameterizetransmissionmodels AT lipsitchmarc someprinciplesforusingepidemiologicstudyresultstoparameterizetransmissionmodels |